Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714232 · ClinicalTrials.gov registry record · NA
Evaluation of Blood Glucose Meter Systems
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01714232 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 106 participants.
The verdict
NCT01714232, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the performance of a Bayer Blood Glucose Monitoring System (BGMS) and four additional Blood Glucose Monitoring Systems (BGMS) from other manufacturers. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).
Interventions
- DEVICE Contour® PLUS BGMS
- DEVICE OneTouch® SelectSimple™ BGMS
- DEVICE Accu-Chek® Performa BGMS
- DEVICE Accu-Chek® Active BGMS
- DEVICE Freestyle Freedom® BGMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01714232
The ClinicalTrials.gov registry entry for NCT01714232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Contour® PLUS BGMS is the first listed.
NCT01714232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01714232 about?
NCT01714232 is a clinical study titled "Evaluation of Blood Glucose Meter Systems". The purpose of this study was to evaluate the performance of a Bayer Blood Glucose Monitoring System (BGMS) and four additional Blood Glucose Monitoring Systems (BGMS) from other manufacturers. All meter BG results were compared with plasma results obtained with a reference laboratory glucose method...
What is the current status of trial NCT01714232?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2012-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01714232?
The interventions under investigation include: Contour® PLUS BGMS (DEVICE), OneTouch® SelectSimple™ BGMS (DEVICE), Accu-Chek® Performa BGMS (DEVICE), Accu-Chek® Active BGMS (DEVICE), Freestyle Freedom® BGMS (DEVICE).
Who is sponsoring clinical trial NCT01714232?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.